Ten organisations whose India centres now shape how medical devices are engineered, how drugs are discovered, and how digital health is built.
India’s healthcare GCC story has moved well past cost arbitrage. Philips, GE HealthCare, Siemens Healthineers, Medtronic, BD, Johnson & Johnson, Roche, Novartis, Abbott, and Stryker now run genuine engineering, AI, and R&D ownership out of India, concentrated mainly in Bengaluru, Hyderabad, Pune, Chennai, and Gurugram. Several of these centres are each company’s largest R&D hub outside its home country.
India’s rise as the world’s Global Capability Centre hub has a distinct healthcare chapter. Banking, retail, and technology built the first wave. Healthcare, medical devices, pharma, and life sciences built a quieter but increasingly consequential second one, visible in the ten centres profiled below.
What began, in most cases, as engineering support has evolved into real ownership: product architecture, AI-led drug discovery, regulatory strategy, and shared services functions that used to sit exclusively at global headquarters.
The Top 10 Healthcare GCCs in India
Philips
Overview
A 130-year-old Dutch health technology company focused on diagnostic imaging, image-guided therapy, and connected care.
India Presence
Pune’s Healthcare Innovation Centre, Bengaluru’s 5,000-person Innovation Campus, Chennai’s Global Business Services hub, and a Gurugram commercial HQ.
What Their GCC Does
Software, AI, and imaging platform engineering in Bengaluru; MRI hardware R&D and manufacturing in Pune; finance, HR, and operations from Chennai.
Why It Matters
Philips treats India as core to its global innovation pipeline, with local R&D feeding products sold in more than 100 countries.
GE HealthCare
Overview
An independent, publicly listed medical imaging and diagnostics leader since its 2024 separation from General Electric.
India Presence
The John F. Welch Technology Centre in Whitefield, Bengaluru, GE’s first and largest R&D centre outside the US, plus a Pune office.
What Their GCC Does
Imaging systems, healthcare software, and digital health platforms, built by a centre with roots stretching back to 2000.
Why It Matters
Few healthcare GCCs carry this institutional history, central to GE‘s long-running “reverse innovation” strategy.
Siemens Healthineers
Overview
A global leader in medical imaging, in-vitro diagnostics, and image-guided therapy.
India Presence
Bengaluru houses the company’s largest R&D centre globally, now integrated with manufacturing and the India commercial HQ on one campus.
What Their GCC Does
More than half of Siemens Healthineers global software engineering workforce, plus data analytics, AI, immersive tech, and cybersecurity.
Why It Matters
One of only four innovation hubs the company runs worldwide, alongside the US, Germany, and China.
Medtronic
Overview
The world’s largest medical device company by most measures, spanning cardiac, surgical, and diabetes technology.
India Presence
The Medtronic Engineering and Innovation Center (MEIC), established 2011, plus a broader commercial network across a dozen-plus cities.
What Their GCC Does
Embedded and enterprise software, robotics, imaging and navigation, surgical and implantable tech, and quality and regulatory functions.
Why It Matters
Medtronic‘s largest R&D centre outside the US, backed by a recent five-year investment exceeding $350 million.
BD (Becton, Dickinson and Company)
Overview
One of the world’s largest medical technology companies, spanning medication management, infection prevention, and diagnostics.
India Presence
A Gurugram commercial HQ, regional offices in five cities, a manufacturing plant in Bawal, and technology campuses in Bengaluru and Chandigarh.
What Their GCC Does
The Bengaluru Technology Campus, opened 2019, spans mechanical, metallurgical, chemical, biomedical, and IT engineering for BD‘s global product pipeline.
Why It Matters
Illustrates a pattern common to newer entrants on this list: a focused engineering mandate growing into a broader strategic footprint.
BD is among the healthcare organizations that have chosen Synq.Work for (Global Capability Centre) GCC Setup in India, reflecting the growing importance of flexible and innovation-driven workspaces for global healthcare capability centers.
Johnson & Johnson
Overview
Johnson & Johnson – A global healthcare leader spanning Innovative Medicine and MedTech, including pharmaceuticals, surgical technology, and orthopaedics.
India Presence
A Bengaluru capability hub, part of a wider network that also includes Manila and Bogotá.
What Their GCC Does
Data and AI delivery for MedTech businesses like orthopaedics, global business services and IT for divisions such as DePuy Synthes, and platform management.
Why It Matters
A newer, actively scaling centre, showing that even the most established global healthcare companies are still expanding their India mandate.
Roche
Overview
Roche One of the world’s largest pharmaceutical and diagnostics companies, researching oncology, immunology, and ophthalmology.
India Presence
Global Analytics and Technology Centres of Excellence (GATE) in Chennai and Hyderabad, plus a longer-standing Pune informatics site from 2015.
What Their GCC Does
Data science and advanced analytics for Roche’s global affiliates across oncology, ophthalmology, and infectious disease, with DevOps expansion planned.
Why It Matters
A deliberate dual-city model, Chennai first, Hyderabad second, building analytics depth in more than one Indian hub.
Novartis
Overview
Novartis – A global pharmaceutical leader researching cardiovascular, oncology, immunology, and neurology treatments.
India Presence
In India since 1947, with a development hub spanning the Novartis Corporate Center and Genome Valley in Hyderabad, plus a newer Mumbai centre.
What Their GCC Does
Global clinical operations, technical R&D, patient safety and pharmacovigilance, regulatory affairs, and quantitative sciences.
Why It Matters
Among the earliest global pharma companies to build genuine India R&D rather than a purely commercial presence, now a scale benchmark.
Abbott
Overview
Abbott – A diversified healthcare company spanning diagnostics, medical devices, nutrition, and generics, and maker of FreeStyle Libre.
India Presence
More than 12,000 employees across India, including three production sites, with a Bengaluru technology presence.
What Their GCC Does
Diagnostics engineering, data analytics, digital health tools, and shared IT and finance services for global functions.
Why It Matters
Blends deep local manufacturing and commercial scale with a genuine global technology mandate, a pattern increasingly common among diversified majors.
Stryker
Overview
Stryker – A leading medical technology company spanning orthopaedics, surgical equipment, neurotechnology, and spine.
India Presence
Commercial operations since 1999 from Gurugram, with the Stryker Global Technology Center (SGTC) established there in 2006.
What Their GCC Does
Systems, mechanical, software, embedded, and computer science engineering, plus a dedicated Neurovascular Innovation Lab.
Why It Matters
Publicly described by Stryker as one of its leading strategic innovation hubs globally, having grown from a narrower support function.
Comparison Table
| Company | Global HQ | Major India GCC Locations | Primary Functions | Approx. India Workforce |
|---|---|---|---|---|
| Philips | Netherlands | Pune, Bengaluru, Chennai, Gurugram | Health tech R&D, software, AI, GBS | 9,000+ (all sites) |
| GE HealthCare | United States | Bengaluru, Pune | Imaging, healthcare software, R&D | Several thousand |
| Siemens Healthineers | Germany | Bengaluru | R&D, software engineering, manufacturing | 50%+ of global software engineers |
| Medtronic | Ireland | Hyderabad | Engineering, robotics, embedded software | 1,400+ |
| BD | United States | Bengaluru, Chandigarh, Gurugram | R&D, software, commercial operations | 440+ (tech campus) |
| Johnson & Johnson | United States | Bengaluru | Data & AI, GBS, IT, MedTech engineering | Not publicly disclosed |
| Roche | Switzerland | Chennai, Hyderabad, Pune | Data science, analytics, informatics | 1,500–2,000+ (Pune) |
| Novartis | Switzerland | Hyderabad, Mumbai | Clinical ops, tech R&D, regulatory, PV | 8,000+ (Hyderabad) |
| Abbott | United States | Bengaluru | Diagnostics engineering, data, shared services | Part of 12,000+ (India-wide) |
| Stryker | United States | Gurugram | R&D engineering, IT, innovation labs | 1,000+ |
Workforce figures are approximate, drawn from company disclosures and industry reporting as of 2026, and reflect each company’s technology or GCC function rather than total India headcount in every case.
Why India Continues to Lead Healthcare GCC Growth
- Talent depth. One of the largest annual STEM graduate pools globally, built for medical software, embedded systems, and clinical data science.
- Engineering ecosystem maturity. Decades of accumulated knowledge in Bengaluru, Hyderabad, and Pune, not just headcount.
- AI and digital transformation. India’s healthcare GCCs increasingly build AI-native products rather than executing instructions from elsewhere.
- Product innovation. Several centres above now own real pieces of global product roadmaps.
- Medical technology specialisation. Regulatory science and device engineering talent has matured enough to compete on capability, not only cost.
- Government support. Telangana and Karnataka in particular have actively courted healthcare and medtech investment.
- Cost advantage. Still real, but now one factor among several rather than the primary justification.
- Innovation ecosystem density. Proximity to India’s wider tech, startup, and academic ecosystem offers partnership options a standalone site would lack.
Future Outlook
Agentic AI is already reshaping how healthcare GCCs operate, with autonomous systems handling continuous execution while human teams shift toward orchestration and governance, showing up in AI-assisted drug discovery and predictive clinical analytics.
Robotics and device engineering are converging further with software, as centres like Medtronic’s Hyderabad hub and Stryker’s Gurugram campus take fuller ownership of connected, software-defined devices.
Digital healthcare platforms, spanning patient data interoperability, remote monitoring, and AI-assisted diagnostics, are likely to see the fastest expansion across nearly every centre on this list.
GCC expansion itself is unlikely to slow. The mandate handed to India’s healthcare centres, R&D ownership, regulatory strategy, product architecture, continues to widen, and India’s role in global medical innovation looks set to deepen over the next decade.
Conclusion
The ten organisations profiled here are not simply running India operations. In most cases, they are running some of their most consequential global work from India: the engineering behind next-generation surgical devices, the analytics behind faster drug discovery, the regulatory science that gets treatments to patients sooner.
That is a markedly different story from the one India’s GCC sector told a decade ago, and the organisations that recognise this shift earliest are setting the pace for the rest of the industry.
Which Healthcare GCC do you believe is setting the benchmark for innovation in India?
